Excel Treatment And Aminokit Release Oral Neutraceutical Formula

Released on: March 28, 2008, 3:17 pm

Press Release Author: Excel Treatment / Tamea Sisco

Industry: Healthcare

Press Release Summary: Excel Treatment and Aminokit, Inc. is announcing the release
of it\'s oral nutraceutical formula.




Press Release Body: Excel Treatment and Aminokit, Inc. is thrilled to announce the
release of it\'s oral nutraceutical formula which has been derived directly from the
amazingly successful intravenous formula. Quickly becoming a world authority on
drug and alcohol detoxification and treatment, Excel is the first facility in the
country to offer the exclusive gamma globulin protein capsule, in two formulas. One
formula for opiates, alcohol and depressants and an second formula for stimulant
users. Where as the IV formula has been critical to achieving sobriety for so many
individuals, the oral formula allows the drug or alcohol user to comfortably
maintain sobriety through stabilization of the neurotransmitter "dopamine", a
neurotransmitter critical to ones survival. That's where our society got the word
"Dope". Dope stimulates dopamine. By repairing the damaged neurotransmitter
mechanism, the brain no longer has the need nor the desire to use anymore. With this
technology and the consistent results in recovery over the last decade, a new
formula for maintaining sobriety has been derived. Not only does the oral formula
minimize cravings, but it helps an individual process daily events of stress while
de-stressing peripheral nerve endings and centralizing focus. All of these benefits
lead to an overall sense of physical and mental wellbeing. While world-wide
distribution has yet to be fully explored, Excel Treatment is currently in search of
a national distributor. There is currently an one eight hundred number for the new
formula: 1-877 "Aminokit"



Web Site: http://www.exceltreatment.com

Contact Details: Excel Treatment
1660 s. Albion St. Ste. 420
Denver, Co. 80222
Phone 1: 1-877-AMINOKIT
Phone 2: 303-782-0599
Fax: 303-782-9062

  • Printer Friendly Format
  • Back to previous page...
  • Back to home page...
  • Submit your press releases...
  •